Skip to main content

Preoperative acute lung injury and oxygenation impairment occurred in the patients with acute aortic dissection

Abstract

Acute lung injury (ALI) and oxygenation impairment (OI) frequently occur in the patients with acute aortic dissection (AAD), which may necessitate mechanical ventilation and result in adverse outcomes. This paper aims to increase clinicians’ awareness of the severe respiratory complications in the patients with AAD, and provide the overview of the epidemiology, adverse outcomes, pathogenesis, predictive markers and therapeutic modalities of the concurrent conditions. Currently, it is considered that inflammatory response plays a great role in the pathogenesis of ALI and OI in the patients with AAD, but the definite pathogenesis remains unclear. Given the great importance of the prediction of the occurrence of the severe respiratory complication at a very early stage, some inflammatory biomarkers have been investigated to predict the occurrence of ALI and OI in several studies. C-reactive protein was found to have a significant predictive effect for the development of ALI and OI. Early use of beta-blockers and the use of bindarit could prevent the occurrence of OI and ALI. Ulinastatin could also improve oxygenation in the patients with type-A AAD. Prevention and management of ALI and OI in AAD remain a great challenge. The definite pathogenesis should be clearly clarified and further studies should be performed to look for potential effective way to predict and manage the severe respiratory conditions.

Peer Review reports

Background

Acute aortic dissection (AAD) is a life-threatening cardiovascular disease associated with high morbidity and mortality. The incidence of aortic dissection is estimated at 4–6 cases per 100,000 person-years [1, 2]. Some fatal complications may potentially occur in the patients with AAD, such as aortic rupture, pericardial tamponade, and multiple organs dysfunction. If untreated, AAD has a mortality rate of 33% within the first 24 h and the mortality rate can rise up to 50% by the first 48 h [3]. Data showed that in-hospital mortality rate was as high as 30% in Stanford type-A AAD and 13% in Stanford type-B AAD [4]. After surgery, the long-term mortality rate ranged from 4 to 48% at 1 year and 9–63% at 5 years for type-B AAD, and similar long-term outcomes could be achieved for type-A AAD [4].

AAD is a systemic disease and some organ damages often occur before operation, such as heart failure, renal and hepatic dysfunction, and neurological deficit. Acute lung injury (ALI) and oxygenation impairment (OI) are critical respiratory conditions, which often occur in the patients with AAD before operation. These preoperative critical complications could result in adverse outcomes [5]. Hence, it is very important to recognize, prevent and manage ALI and OI in the patients with AAD. However, they still remain great challenges in clinical practice. And some doctors are even not aware of the severe respiratory complications.

To our knowledge, there are no definite current guidelines for the pathogenesis, prevention and management of the critical respiratory complications. Limited information has been known on them and therapeutic measurements are usually based on the doctor’s preference. We have comprehensively reviewed the articles focused on this area in the literature with the aim of increasing the knowledge of the critical respiratory complications occurred in the patients with AAD for the doctors and helping them to improve this practice and patient prognosis.

Clinical characteristics and diagnosis

ALI is the term given to the pathophysiologic presentation of diffuse alveolar injury. It presents as acute hypoxemia with bilateral pulmonary infiltrates on chest imaging that can’t be explained by cardiogenic pulmonary edema [6]. The radiologic hallmarks are the geographic distribution of the patchy ground glass densities, areas of lobular sparing and lower lobe consolidation [7]. The disorder is defined as a syndrome of inflammation and increased pulmonary membrane permeability. Lung compliance is substantially decreased. It can have several etiologies that are systemic, rather than pulmonary and cardiogenic. In 1994, the American-European Consensus Conference Committee established the definition of ALI and acute respiratory distress syndrome (ARDS). The definition included three criteria: (1) the acute onset of diffuse bilateral infiltrates by chest radiography; (2) A PaO2/FiO2 ratio ≤ 300 for ALI and ≤ 200 for ARDS; (3) Pulmonary artery wedge pressure should be no more than 18, or there is no clinical evidence of left atrial hypertension [8, 9].

For the patients with AAD, ALI often occurs within a few days after the onset of symptoms. To our knowledge, symptoms, signs and radiologic features of the ALI in the patients with AAD have not been descripted in the literature. According to our experience, the symptoms and signs depend on the oxygen levels in blood and the patients’ tolerability for the hypoxemia. The patients may have shortness of breath, tachypnea, and a bluish color in the fingers, lips and toes. If hypoxemia is not severe, some patients may not have any symptoms and signs related to the ALI. The radiological examination is not usually required due to the critical nature of AAD and the results of the laboratory tests are non-specific. ALI is usually diagnosed according to the PaO2/FiO2 ratio. In the related articles published in the literature, ALI was defined as PaO2/FiO2 ≤ 300 and OI was defined as PaO2/FiO2 ≤ 200.

Epidemiology

There are many reports which estimated the incidence of ALI and OI occurred in the patients with AAD. However, the true incidence is unknown due to the limited sample in each single institution. There are 2 reports on the incidence of ALI complicated by Stanford type-A AAD in the literature, which was 53.8% [10] and 46.5% [11] respectively. And there are 6 articles on the incidence of OI complicated by AAD since the year 2000, which was reported to be 32.2–51% [12,13,14,15,16,17]. Among the patients with OI, about 31.6–48.4% patients were reported to necessitate mechanical ventilation [14, 15, 17, 18].

Adverse outcomes

The patients with ALI and OI frequently necessitate mechanical ventilation [17], which may cause ventilator-associated pneumonia and ventilator-associated lung injury [18]. Preoperative OI may result in surgery delay, leading to the increasing risk for higher morbidity and mortality [19]. And some patients may refuse surgery because of the higher perioperative risks estimated. Severe hypoxemia can also occur during surgery even if with the support of mechanical ventilation, increasing the difficulty to maintain satisfactory saturation of blood oxygen for anesthetists. A recent study indicated that patients with ALI had a significant higher morbidity, and the median intubation time, length of stay in intensive critical unit, and length of hospital stay were significantly longer [11]. Gao et al. reported that OI could result in more intraoperative blood loss, longer mechanical ventilation time, and longer stay in intensive critical unit and hospital [13]. Wang et al. reported that preoperative OI is an independent predictor of postoperative hypoxemia (49.5%) in Stanford-A aortic dissection [20]. Hence, it is very important to prevent and manage ALI and OI to decrease the possibility of composite morbidities.

Pathogenesis

The definite pathogenesis of ALI and OI complicated by AAD remains unclear. However, it is currently considered that systemic inflammatory reactions play great roles in the pathogenesis of ALI and the development of OI. After the aortic injuries, the long-term chronic inflammation in the aortic wall rapidly develops to acute inflammation [15, 18]. A large amount of macrophages infiltration was revealed in the aortic samples from the patients with aortic dissection [21]. And a large number of cytokines including IL-6 and IL-17 have also been found infiltrating the aorta in the patients with aortic dissection [22]. The protective local inflammation may turn to be excessive systemic inflammatory reactions and result in untoward consequences including the organs damage. Additionally, impaired multiple organ perfusion due to the dissection of the entire aorta can also aggravate systemic inflammatory response [23]. Since the pulmonary vascular bed is an important reservoir of neutrophils, the lungs tend to be a major site of tissue damage by AAD [19]. The clinical characteristics of refractory hypoxemia attributes to alveolar edema in inflammatory states when fluid can leak across alveolar-capillary barrier due to the increased permeability [24]. It was suggested that the rapid inflammatory reactions other than the chronic inflammation predominantly contributed to the development of OI [17].

A few studies have been conducted on the mechanisms of the development of ALI and OI complicated by AAD (Fig. 1). It has been reported that ALI complicated by AAD was highly associated with the macrophages infiltrating the pulmonary interstitial tissues and releasing matrix metalloproteinases 9 [25]. Wu et al. demonstrated that angiotensin II was closely related to the lung injury at the early stage of AAD through mediating the release of matrix metalloproteinases 9 in the macrophages in the lung tissues [26]. Angiotensin II was indicated to induce pulmonary injury by triggering endothelial barrier injury, and such process may be related to the dephosphorylation of Y-685-VE-cadherin and endothelial skeletal rearrangement [27]. Angiotensin II also could induce the production of monocyte chemoattractant-1 and cellular apoptosis in human pulmonary microvascular endothelial cells, which was closely related to the pathogenesis of ALI in AAD [28].

Fig. 1
figure 1

There are three major possible mechanisms of ALI complicated by AAD. (1) AngII could trigger overexpression of MCP-1 in PMVECs by activating NF-κB signaling pathway. MCP-1 plays a great role in the recruitment of macrophages in lung tissues, and MMP-9 derived from macrophages could induce the degradation of extracellular matrix and vascular basilar membrane; (2) AngII could induce the apoptosis of PMVECs through activating the caspase-3, up-regulating the expression of Bax and down-regulating the expression of Bcl-2; (3) AngII could trigger endothelial barrier injury, which may be related to the dephosphorylation of Y685-VE-cadherin and the endothelial skeletal rearrangement. AngII angiotensin II, MCP-1, monocyte chemoattractant protein-1, PMVECs pulmonary microvascular endothelial cells, MMP-9, matrix metalloproteinase 9

In addition, Gao and his colleagues suggested that coagulation and fibrinolysis appeared to play critical roles in the pathogenesis of OI development [13]. Another study indicated that oxidative stress might be involved in the process of ALI in obese patients with aortic dissection, because obese patients seemed to have high risks for the development of ALI [29].

Predictive markers

ALI and OI can result in some adverse outcomes, so identification prior to the occurrence of them is very important. The patients with high risks for developing ALI and OI can receive surgical treatment and some other appropriate therapies at the very early stage after the symptom onset. It can help patients gain better prognosis. Hence, it is very necessary to evaluate the predictive value of some biomarkers in the development of ALI and OI complicated by AAD.

A few reports showed the independent association between the patients’ clinical characteristics and OI or ALI development complicated by AAD. Kazunori Tomita and his colleagues demonstrated that non-slender frame, temperature on admission ≥ 36.5 °C and lower oxygenation index on admission were reliable for predicting the occurrence OI in type-B AAD [16]. Yusuke Kashiwagi reported that OI in type-B AAD was correlated with younger age [18]. In OI group, the peak body temperature was also found to be significantly elevated [15, 17]. A recent study indicated that older patients, obese patients and preoperative diastolic blood pressure < 44 mmHg were independent factor related to the occurrence of preoperative ALI in Stanford type-A AAD [10]. It was also suggested that systolic blood pressure and positive smoking history were associated with the occurrence of preoperative ALI in Stanford type-A AAD [11]. However, some other studies did not find any relationship between patients’ demography and OI development [11, 12, 14, 30]. Generally speaking, the solid consensus has not yet been reached on the association between the patients’ characteristics and the development of OI and ALI. Further studies with large samples should be established to gain more reliable conclusions.

Given the vital roles of the inflammatory reactions in the occurrence of ALI and OI in the patients with AAD, some inflammatory biomarkers were investigated to predict the ALI and OI development in AAD. A few studies indicated that the peak levels of C-reactive protein after admission was an independent predictor of OI development [12, 15, 18, 30]. Our previous study also suggested that serum C-reactive protein and albumin measured on admission were independent predictors of OI development in the hypertensive patients with AAD [17]. In the patients with OI, white blood cell levels could be elevated [11, 15]. It has been reported that patients with high mean platelet volume/platelet count ratio had a high risk of preoperative ALI [31]. Some interleukins were also investigated. In 1999, a study indicated that IL-8 might be associated with OI development [32]. A recent study reported that IL-6 and prostaglandin I2/thromboxane B2 ratio were independent factors related to the occurrence of preoperative ALI in Stanford type-A AAD [11]. Duan et al. also reported that IL-6 could be an independent predictive factor for OI development in Stanford type-A AAD [30].

Based on the important roles of coagulation and fibrinolysis in OI development, a recent study demonstrated that preoperative plasminogen activator inhibitor-1 in bronchoalveolar lavage fluid and tissue factor in both serum and bronchoalveolar lavage fluid were significant factors related to the development for OI in patients with Stanford type-A AAD [13]. Recent studies showed that D-dimer and fibrinogen and fibrin degradation products (FDP) were not associated with the occurrence of ALI and OI in the patients with AAD [17, 18]. AAD% (the percentage of the volume of false lumen to that of aorta in the descending aorta) could possibly show the magnitude of the systemic inflammatory reactions to the aortic injury, and it was demonstrated as the independent predictor of OI in distal type AAD by Manabu Kurabayashi and his colleagues [14]. It provided a non-invasive and easy-to-use alternative to evaluate the possibility of developing ALI and OI at the early stage after admission. Of course, ideal biomarkers should be further introduced to predict the critical respiratory complications with good sensitivity and specificity.

Therapeutic modalities

Surgery is the mainstay treatment for AAD, but surgical strategy for the patients complicated with ALI and OI has not been established. The operation timing usually accords to the doctors’ preference and no evidence has been reported to determine the appropriate operation timing. Concerning about the adverse outcomes of the respiratory complications on the surgery, doctors sometimes may choose conservative therapy until the state of ALI and OI has been ameliorated. This may lead to the occurrence of some potential fatal complications due to the surgery delay. According to our practical experience, we suggest that surgery for the patients with ALI and OI should be performed at the very early stage after occurrence of them. We guess that it is mainly because surgical closure of the intimal tears may diminish the inflammatory reactions surrounded by the aortic injuries and it may further ameliorate systemic inflammatory reactions. The patients with high risks for developing ALI and OI should also been closely monitored and timely surgical treatment may be helpful to improve prognosis. And the development of ALI and OI should not be the contraindication of the surgery. As we know, it has not been reported about the association between the severe respiratory state and the perioperative survival rate. Detailed data should be reported to help us determine appropriate therapeutic modalities.

Some agents have been investigated to attenuate ALI and OI. Yusuke Jo and his colleagues indicated that use of beta-blockers within 24 h of the onset of AAD could prevent OI [33]. It has been reported that patients with type-A AAD who received ulinastatin at a total dose of 30,000 units prior to surgery could have better oxygenation compared with the patients not receiving ulinastatin [30]. Bindarit, an indazolic derivative, was found to have a significant effect to attenuate the incidence of AAD complicated ALI and inhibit the accumulation of macrophages in lung tissues in rat model, which might be associated with downregulation of the classical nuclear factor kappa-B pathway [34]. Some other studies also provided new insight to look for new potential therapeutic modalities for the concurrent conditions. IL-22 might attenuate ALI induced by angiotensin II because IL-22 contributed to the inhibition of pulmonary microvascular endothelial cells apoptosis mediated by angiotensin II through activating the JAK2/STAT3 signaling pathway [35, 36]. Given oxidative stress and inflammatory response may be involved in the process of ALI of aortic dissection caused by obesity, it may provide new ideas for the treatment of ALI after aortic dissection [29]. It was reported that pretreatment with pravastatin could protect against ischemia-repfusion induced lung injury in an experimental animal model with AAD [37], so potential protective effect of pravastatin for the patients with AAD complicated with OI and ALI may be worthy of investigating in future. Corticosteroids have a wide spectrum of potentially desired actions including anti-inflammatory, antioxidant, pulmonary vasodilator and anti-edematous effects. So we hypothesize that short-term and low-dose administration of corticosteroids should have protective role in the pathogenesis of ALI. And we will investigate the role of corticosteroids in the prevention and therapeutic management of ALI in the patients of AAD in further study.

Conclusions

ALI and OI are adverse complications frequently occurred in the patients with AAD. Currently the awareness of the severe respiratory conditions is not enough and the information in the literature is relatively limited. It is very difficult to establish guidelines for epidemiology, pathogenesis, prevention, treatment, and prognosis. The management of ALI and OI seems to be blind in clinical practice and it often accords to the doctors’ own preference. Hence, further study should be performed to clarify the pathogenesis of ALI and OI complicated in AAD, and some potential effective ways need to be explored to prevent and manage the ALI and OI.

Availability of data and materials

The datasets used and/or analyzed in this present study are available from the corresponding author on reasonable request.

Abbreviations

ALI:

Acute lung injury

OI:

Oxygenation impairment

AAD:

Acute aortic dissection

References

  1. Erbel R, Aboyans V, Boileau C, Bossone E, Bartolomeo RD, Eggebrecht H, et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The task force for the diagnosis and treatment of aortic diseases of the European Society of Cardiology (ESC). Eur Heart J. 2014;35(41):2873–926.

    Article  Google Scholar 

  2. Gawinecka J, Schonrath F, von Eckardstein A. Acute aortic dissection: pathogenesis, risk factors and diagnosis. Swiss Med Wkly. 2017;147:w14489.

    PubMed  Google Scholar 

  3. De Leon Ayala IA, Chen YF. Acute aortic dissection: an update. Kaohsiung J Med Sci. 2012;28(6):299–305.

    Article  Google Scholar 

  4. Gao Y, Li D, Cao Y, Zhu X, Zeng Z, Tang L. Prognostic value of serum albumin for patients with acute aortic dissection: a retrospective cohort study. Medicine (Baltimore). 2019;98(6):e14486.

    Article  CAS  Google Scholar 

  5. Wang TKM, Wei D, Evans T, Ramanathan T, Haydock D. Surgery for type A aortic dissection: 14-year contemporary cohort study. Heart Lung Circ. 2020;29(8):1210–6.

    Article  Google Scholar 

  6. Sweeney RM, McAuley DF. Acute respiratory distress syndrome. Lancet. 2016;388(10058):2416–30.

    Article  Google Scholar 

  7. Zompatori M, Ciccarese F, Fasano L. Overview of current lung imaging in acute respiratory distress syndrome. Eur Respir Rev. 2014;23(134):519–30.

    Article  Google Scholar 

  8. Mowery NT, Terzian WTH, Nelson AC. Acute lung injury. Curr Probl Surg. 2020;57(5):100777.

    Article  Google Scholar 

  9. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. Report of the American–European Consensus conference on acute respiratory distress syndrome: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Consensus Committee. J Crit Care. 1994;9(1):72–81.

    Article  CAS  Google Scholar 

  10. Pan X, Lu J, Cheng W, Yang Y, Zhu J, Jin M. Independent factors related to preoperative acute lung injury in 130 adults undergoing Stanford type-A acute aortic dissection surgery: a single-center cross-sectional clinical study. J Thorac Dis. 2018;10(7):4413–23.

    Article  Google Scholar 

  11. Guo Z, Yang Y, Zhao M, Zhang B, Lu J, Jin M, et al. Preoperative hypoxemia in patients with type A acute aortic dissection: a retrospective study on incidence, related factors and clinical significance. J Thorac Dis. 2019;11(12):5390–7.

    Article  Google Scholar 

  12. Komukai K, Shibata T, Mochizuki S. C-reactive protein is related to impaired oxygenation in patients with acute aortic dissection. Int Heart J. 2005;46(5):795–9.

    Article  CAS  Google Scholar 

  13. Gao Z, Pei X, He C, Wang Y, Lu J, Jin M, et al. Oxygenation impairment in patients with acute aortic dissection is associated with disorders of coagulation and fibrinolysis: a prospective observational study. J Thorac Dis. 2019;11(4):1190–201.

    Article  Google Scholar 

  14. Kurabayashi M, Okishige K, Azegami K, Ueshima D, Sugiyama K, Shimura T, et al. Reduction of the PaO2/FiO2 ratio in acute aortic dissection—relationship between the extent of dissection and inflammation. Circ J. 2010;74(10):2066–73.

    Article  Google Scholar 

  15. Sugano Y, Anzai T, Yoshikawa T, Satoh T, Iwanaga S, Hayashi T, et al. Serum C-reactive protein elevation predicts poor clinical outcome in patients with distal type acute aortic dissection: association with the occurrence of oxygenation impairment. Int J Cardiol. 2005;102(1):39–45.

    Article  Google Scholar 

  16. Tomita K, Hata N, Kobayashi N, Shinada T, Shirakabe A. Predicting the occurrence of oxygenation impairment in patients with type-B acute aortic dissection. Int J Angiol. 2014;23(1):53–60.

    Article  Google Scholar 

  17. Zhao X, Bie M. Predictors for the development of preoperative oxygenation impairment in acute aortic dissection in hypertensive patients. BMC Cardiovasc Disord. 2020;20(1):365.

    Article  CAS  Google Scholar 

  18. Kashiwagi Y, Komukai K, Suzuki K, Oi Y, Tominaga M, Nakata K, et al. Predictors of oxygenation impairment in medical treatment for type B acute aortic dissection. Heart Vessels. 2018;33(12):1463–70.

    Article  Google Scholar 

  19. Cheng Y, Jin M, Dong X, Sun L, Liu J, Wang R, et al. Mechanism and early intervention research on ALI during emergence surgery of Stanford type-A AAD: Study protocol for a prospective, double-blind, clinical trial. Medicine (Baltimore). 2016;95(42):e5164.

    Article  Google Scholar 

  20. Wang Y, Xue S, Zhu H. Risk factors for postoperative hypoxemia in patients undergoing Stanford A aortic dissection surgery. J Cardiothorac Surg. 2013;30(8):118.

    Article  Google Scholar 

  21. Wang X, Zhang H, Cao L, He Y, Ma A, Guo W. The role of macrophages in aortic dissection. Front Physiol. 2020;11:54.

    Article  CAS  Google Scholar 

  22. Zeng T, Yuan J, Gan J, Liu Y, Shi L, Lu Z, et al. Thrombospondin 1 is increased in the aorta and plasma of patients with acute aortic dissection. Can J Cardiol. 2019;35(1):42–50.

    Article  Google Scholar 

  23. Iscan S, Gokalp O, Donmez K, Lafci B. About inflammatory activation during aortic dissection. Anatol J Cardiol. 2018;20(5):306.

    PubMed  PubMed Central  Google Scholar 

  24. Piantadosi CA, Schwartz DA. The acute respiratory distress syndrome. Ann Intern Med. 2004;141(6):460–70.

    Article  Google Scholar 

  25. Wu Z, Wang Z, Xu P, Zhang M, Cheng L, Gong B. A novel finding: macrophages involved in inflammation participate in acute aortic dissection complicated with acute lung injury. Curr Mol Med. 2017;17(8):568–79.

    Article  CAS  Google Scholar 

  26. Wu Z, Ruan Y, Chang J, Li B, Ren W. Angiotensin II is related to the acute aortic dissection complicated with lung injury through mediating the release of MMP9 from macrophages. Am J Transl Res. 2016;8(3):1426–36.

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Wu Z, Wang Z, Dai F, Liu H, Ren W, Chang J, et al. Dephosphorylation of Y685-VE-cadherin involved in pulmonary microvascular endothelial barrier injury induced by angiotensin II. Mediators Inflamm. 2016;2016:8696481.

    PubMed  PubMed Central  Google Scholar 

  28. Wu Z, Dai F, Ren W, Liu H, Li B, Chang J. Angiotensin II induces apoptosis of human pulmonary microvascular endothelial cells in acute aortic dissection complicated with lung injury patients through modulating the expression of monocyte chemoattractant protein-1. Am J Transl Res. 2016;8(1):28–36.

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Wu Z, Wang Z, Wu H, Hu R, Ren W, Hu Z, et al. Obesity is a risk factor for preoperative hypoxemia in Stanford A acute aortic dissection. Medicine (Baltimore). 2020;99(11):e19186.

    Article  CAS  Google Scholar 

  30. Duan XZ, Xu ZY, Lu FL, Han L, Tang YF, Tang H, et al. Inflammation is related to preoperative hypoxemia in patients with acute Stanford type A aortic dissection. J Thorac Dis. 2018;10(3):1628–34.

    Article  Google Scholar 

  31. Li DZ, Chen QJ, Sun HP, Zeng R, Zeng Z, Gao XM, et al. Mean platelet volume to platelet count ratio predicts in-hospital complications and long-term mortality in type A acute aortic dissection. Blood Coagul Fibrinolysis. 2016;27(6):653–9.

    Article  Google Scholar 

  32. Hasegawa Y, Ishikawa S, Ohtaki A, Otani Y, Takahashi T, Sato Y, et al. Impaired lung oxygenation in acute aortic dissection. J Cardiovasc Surg (Torino). 1999;40(2):191–5.

    CAS  Google Scholar 

  33. Jo Y, Anzai T, Sugano Y, Naito K, Ueno K, Kohno T, et al. Early use of beta-blockers attenuates systemic inflammatory response and lung oxygenation impairment after distal type acute aortic dissection. Heart Vessels. 2008;23(5):334–40.

    Article  Google Scholar 

  34. Wu Z, Chang J, Ren W, Hu Z, Li B, Liu H. Bindarit reduces the incidence of acute aortic dissection complicated lung injury via modulating NF-kappaB pathway. Exp Ther Med. 2017;14(3):2613–8.

    Article  CAS  Google Scholar 

  35. Ren W, Wang Z, Wu Z, Hu Z, Dai F, Chang J, et al. JAK2/STAT3 pathway was associated with the protective effects of IL-22 On aortic dissection with acute lung injury. Dis Mark. 2017;2017:1917804.

    Google Scholar 

  36. Ren W, Wang Z, Wu Z, Hu Z, Dai F, Chang J, et al. Corrigendum to “JAK2/STAT3 pathway was associated with the protective effects of IL-22 on aortic dissection with acute lung injury.” Dis Mark. 2019;2019:1901626.

    Google Scholar 

  37. Joyce M, Kelly CJ, Chen G, Bouchier-Hayes DJ. Pravastatin attenuates lower torso ischaemia-reperfusion-induced lung injury by upregulating constitutive endothelial nitric oxide synthase. Eur J Vasc Endovasc Surg. 2001;21(4):295–300.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Professor Hu Yanming for assistance with improvement in English. No one else than the authors have participated in the design and preparation of this article.

Funding

This study was not supported by funding.

Author information

Authors and Affiliations

Authors

Contributions

BM conceived the idea. ZX and BM drafted the manuscript, and then BM reviewed the manuscript. Both authors read and approved the final draft.

Corresponding author

Correspondence to Mengjun Bie.

Ethics declarations

Ethics approval and consent to participate

This study was carried out following the international ethical recommendations for medical research in humans. Both authors were sure that this study was conducted in accordance with the standards set out in the Declaration of Helsinki. Before starting the study, the Ethical Committee of the first affiliated hospital of Chongqing Medical University approved the study protocol.

Consent for publication

Not applicable.

Competing interests

There is no competing interest to declare in this study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhao, X., Bie, M. Preoperative acute lung injury and oxygenation impairment occurred in the patients with acute aortic dissection. BMC Cardiovasc Disord 22, 129 (2022). https://doi.org/10.1186/s12872-022-02579-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12872-022-02579-9

Keywords